Acute pancreatitis remains a clinical challenge, despite an exponential increase in our
knowledge of its complex pathophysiological changes. Early fluid therapy is the cornerstone …

Purpose of review Despite the increasing incidence of acute pancreatitis, the overall
mortality of AP has decreased. Recent findings The findings of recent studies on fluid …

Abstract Background/Aims Hematocrit is a widely used biomarker to guide early fluid therapy
for patients with acute pancreatitis (AP), but there is controversy over whether early rapid …

Introduction Earlier national surveys on the management of acute pancreatitis (AP) had
reported non-compliance to practice guidelines. In the past decade, several guidelines were …

Background The initial management of patients with acute pancreatitis impacts both
morbidity and mortality. Point‐of‐care decisions have been reported to differ from clinical …

Abstract Background/Objectives Acute pancreatitis management guidelines recommend
early aggressive hydration to improve clinical outcomes. We aim to evaluate the influence of …

Background Controversies existed surrounding the use of hematocrit to guide early fluid
therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy …

Introduction Prescribing intravenous (IV) fluid therapy is a core skill expected of qualified
doctors at the point of graduation, but medical graduates often feel ill-equipped to perform …

Objectives The primary end point was the compliance rate with guidelines. The secondaries
were mortality, hospital stay, and costs. Methods This study included 1904 patients with …

Objectives Analgesia and intravenous fluid resuscitation are cornerstones of initial patient
management in acute pancreatitis (AP). The aim was to investigate the effect of intravenous …